Prasugrel (CS-747, LY640315) Hydrochloride, a Novel Thienopyridine Prodrug, Shows Potent Antiplatelet and Antithrombotic Effects with Rapid Onset of Action in Rats.
Y. Niitsu(Daiichi-Sankyo (Japan)), Fumitoshi Asai(Azabu University), Yuki Yokouchi, Mayumi Kakusaka, Taketoshi Ogawa(Biomedical Research Laboratories (United States)), Michihiro Hasegawa, Joseph A. Jakubowski(Indiana Biosciences Research Institute), Atsuhiro Sugidachi(Daiichi Sankyo (United Kingdom))
Cited by 0
Related Papers
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention
|Circulation|2007|882
Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
|New England Journal of Medicine|2013|651
A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents
|Journal of the American College of Cardiology|2012|617